Nothing Special   »   [go: up one dir, main page]

GR880300115T1 - 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them - Google Patents

1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
GR880300115T1
GR880300115T1 GR88300115T GR880300115T GR880300115T1 GR 880300115 T1 GR880300115 T1 GR 880300115T1 GR 88300115 T GR88300115 T GR 88300115T GR 880300115 T GR880300115 T GR 880300115T GR 880300115 T1 GR880300115 T1 GR 880300115T1
Authority
GR
Greece
Prior art keywords
diones
alkyl
androsta
diene
alpha
Prior art date
Application number
GR88300115T
Other languages
English (en)
Inventor
Ulrich Kerb
Yukishige Nishino
David Henderson
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of GR880300115T1 publication Critical patent/GR880300115T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR88300115T 1985-11-01 1989-06-22 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them GR880300115T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853539244 DE3539244A1 (de) 1985-11-01 1985-11-01 1-methyl-15(alpha)-alkyl-androsta- 1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
GR880300115T1 true GR880300115T1 (en) 1989-06-22

Family

ID=6285220

Family Applications (1)

Application Number Title Priority Date Filing Date
GR88300115T GR880300115T1 (en) 1985-11-01 1989-06-22 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
EP (1) EP0225272B1 (el)
JP (1) JPS62155294A (el)
CN (1) CN86107158A (el)
AT (1) ATE41936T1 (el)
AU (1) AU6432986A (el)
DD (1) DD250319A5 (el)
DE (2) DE3539244A1 (el)
DK (1) DK515486A (el)
FI (1) FI864329A (el)
GR (1) GR880300115T1 (el)
HU (1) HU196079B (el)
IL (1) IL80176A0 (el)
NO (1) NO864365L (el)
NZ (1) NZ218071A (el)
PT (1) PT83659B (el)
ZA (1) ZA868333B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703722A1 (de) * 1987-02-04 1988-08-18 Schering Ag 1-methyl-15(alpha)-(1,2-dialkanoyloxyalkyl)-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
CN86107158A (zh) 1987-08-05
HU196079B (en) 1988-09-28
AU6432986A (en) 1987-05-07
PT83659B (en) 1988-08-30
FI864329A (fi) 1987-05-02
NZ218071A (en) 1989-01-06
ATE41936T1 (de) 1989-04-15
ZA868333B (en) 1987-06-24
JPS62155294A (ja) 1987-07-10
PT83659A (en) 1986-11-01
FI864329A0 (fi) 1986-10-24
NO864365L (no) 1987-05-04
HUT43618A (en) 1987-11-30
DK515486D0 (da) 1986-10-28
IL80176A0 (en) 1986-12-31
EP0225272A1 (de) 1987-06-10
EP0225272B1 (de) 1989-04-05
DK515486A (da) 1987-05-02
DE3662693D1 (en) 1989-05-11
DD250319A5 (de) 1987-10-08
DE3539244A1 (de) 1987-05-07
NO864365D0 (no) 1986-10-31

Similar Documents

Publication Publication Date Title
DE3570038D1 (en) Steroids for use as immunomodulators
AU7478087A (en) Process for the preparation of (2,2)-paracyclophane and derivatives thereof
AU5936386A (en) Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them
DE3266035D1 (en) Unsaturated aryl ketones as antiseborrhoeic additives for cosmetic compositions
RO86647B (ro) Procedeu pentru prepararea unor derivati de 4''-epieritromicina
AU579497B2 (en) Peptic ulcer treatment method
DE3662693D1 (en) 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them
RO93593B (ro) Procedeu de preparare a unor 6-alfa-metilcorticoizi
DE3571441D1 (en) Process for the preparation of pregnane derivative
AU5847386A (en) Derivatives of 1,1,2,2-tetramethyl-1,2-bis-(2-fluoro-4- hydroxphenyl)-ethane
AU584098B2 (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
IL84364A0 (en) 4-hydroxy-4-(substituted alkenyl)-cyclohexanecarboxylic acids,process for their preparation and pharmaceutical compositions containing same
JPS5268196A (en) Bicyclomycin derivatives
EP0322248A3 (en) Compounds effective against cerebral insufficiency
IL67323A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same